Repositrak, Inc. (TRAK) - 10-Q Summary
Business Context and Reporting Period
Company: Repositrak, Inc. (formerly Park City Group, Inc.)
Reporting Period: Quarter and nine months ended March 31, 2025 (Fiscal Year 2025)
Business Model: B2B SaaS provider offering compliance, traceability, and supply chain management solutions. The company operates on a "hub and spoke" model, engaging retailers/wholesalers who mandate supplier participation.
Key Drivers: Growth is driven by regulatory mandates (FSMA 204) and retailer requirements for food traceability.
Key Financial Metrics
| Metric (Nine Months Ended Mar 31, 2025) | Value |
|---|---|
| Revenue | $16,845,782 |
| Net Income | $5,182,023 |
| Net Income Applicable to Common Shareholders | $4,892,800 |
| Diluted EPS | $0.26 |
| Operating Cash Flow | $6,763,371 |
| Cash and Cash Equivalents (Mar 31, 2025) | $28,134,321 |
| Total Debt | $561,949 (Financing leases only; no bank debt) |
| Working Capital | $27,318,199 |
| Current Ratio | 6.03 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 10% year-over-year (YoY) for the nine months ended March 31, 2025, compared to the prior year. Quarterly revenue (Q3) grew 16% YoY. Growth is attributed to recurring subscription revenue across compliance, supply chain, and traceability lines.
- Profitability: Net income increased 18% YoY to $5.18 million. Operating income rose to $4.64 million (26% increase YoY).
- Expense Management: Cost of revenue increased 8% YoY, primarily due to hiring development personnel to automate onboarding for the FSMA 204 initiative. Sales and marketing expenses rose 7% YoY due to commissions and traceability marketing.
- Capital Structure: The company terminated its $10 million revolving credit facility in March 2024 due to strong liquidity. It continues to redeem Series B Preferred Stock, reducing preferred dividends by 32% YoY.
- Cash Position: Cash balances increased 12% from the prior fiscal year-end, driven by operating cash flows and advance payments from annual subscriptions.
Guidance, Outlook, and Risks
- Regulatory Outlook: The FDA extended the FSMA 204 compliance deadline to July 20, 2028. However, major retailers are mandating traceability requirements earlier (e.g., June 30, 2025), driving near-term demand.
- Dividends: The company declared a quarterly cash dividend of $0.01815 per share. Management anticipates continued quarterly dividends.
- Share Repurchases: The company has $7.89 million remaining under its share repurchase program. It repurchased $100,016 of stock in the nine-month period.
- Interest Rate Risk: Management notes that Federal Reserve rate cuts may reduce future interest income on cash balances, though the company maintains a high cash yield (4.84% weighted average).
- Bad Debt: Bad debt expense increased to $450,000 for the nine-month period, double the prior year amount, though the allowance for doubtful accounts remains manageable relative to receivables.
Investor Verification Checklist
- FSMA 204 Adoption Rate: Verify the actual uptake of the Repositrak Traceability Network (RTN) as the July 2028 deadline approaches and retailer mandates tighten.
- Customer Concentration: Assess reliance on major "Hub" retailers (multi-store chains) whose mandates drive the "Spoke" supplier base.
- Preferred Stock Redemption: Confirm the timeline and cash impact of the remaining $4.35 million in preferred stock redemptions.
- Interest Income Sustainability: Monitor the impact of falling interest rates on the company's significant cash balance ($28.1M) and overall net income.
- Bad Debt Trends: Review the $450,000 bad debt expense increase to ensure it does not signal broader collection issues with the supplier base.